NHWA Pharma. Corporation

Patent Applications and Registrations

Patent applications and USPTO patent grants for NHWA Pharma. Corporation.The latest application filed is for "impurities of amide-like derivatives and use thereof".

Company Profile

3.17.11

NHWA Pharma. Corporation - Xuzhou, Jiangsu CN
NHWA PHARMA. CORPORATION - Jiangsu CN
NHWA PHARMA. CORPORATION - Xuzhou CN
NHWA PHARMA. CORPORATION - Xuzhou City, Jiangsu CN
NHWA Pharma. Corporation - CN CN
NHWA PHARMA. CORPORATION - Xuzhou City CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Impurities Of Amide-like Derivatives And Use Thereof App 20220048887 - DOU; Fei ; et al.	2022-02-17
Crystalline Form Of Propanamide Derivative And Preparation Method Therefor App 20220024905 - HAO; Chao	2022-01-27
Fused heterocyclic compound derivative and application thereof Grant 10,517,862 - Zhang , et al. Dec	2019-12-31
Lactam compound derivative and application thereof Grant 10,501,452 - Chen , et al. Dec	2019-12-10
Lactam Compound Derivative And Application Thereof App 20180327397 - CHEN; Yin ; et al.	2018-11-15
Fused Heterocyclic Compound Derivative And Application Thereof App 20180318286 - Zhang; Guisen ; et al.	2018-11-08
3-[(Benzo[D][1,3]dioxolan-4-yl)-oxy]-3-arylpropylamine type compounds and applications thereof Grant 10,093,644 - Guo , et al. October 9, 2	2018-10-09
3-[(benzo[d][1,3]dioxolan-4-yl)-oxy]-3-arylpropylamine Type Compounds And Applications Thereof App 20170369466 - Guo; Qiang ; et al.	2017-12-28
Benzopyrone derivative and use thereof Grant 9,315,496 - Zhang , et al. April 19, 2	2016-04-19
3-cyanoanilinoalkylarylpiperazine derivative and use thereof in preparing drugs Grant 9,238,632 - Li , et al. January 19, 2	2016-01-19
Alicyclic[c] benzopyrone derivatives and uses thereof Grant 9,018,213 - Zhang , et al. April 28, 2	2015-04-28
3-cyanoanilinoalkylarylpiperazine Derivative And Use Thereof In Preparing Drugs App 20150105399 - Li; Jianqi ; et al.	2015-04-16
[1,3,4] oxadiazole derivative and application thereof Grant 8,993,575 - Zhang , et al. March 31, 2	2015-03-31
Substituted phenylpiperazinyl aralkylalcohol derivatives, pharmaceutical compositions containing such derivatives and uses thereof Grant 8,778,948 - Li , et al. July 15, 2	2014-07-15
Benzopyrone Derivative And Use Thereof App 20140113911 - Zhang; Guisen ; et al.	2014-04-24
Process for the manufacture of agomelatine and its intermediate Grant 8,653,281 - Zhang , et al. February 18, 2	2014-02-18
Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent Grant 8,501,778 - Li , et al. August 6, 2	2013-08-06
Use of aryl piperazine derivatives in manufacturing medicants for treating pain Grant 8,420,652 - Zhang , et al. April 16, 2	2013-04-16
Benzisoxazole Piperidinyl Derivatives, Pharmaceutical Compositions Comprising The Derivatives And Their Use App 20110306638 - Li; Jianqi ; et al.	2011-12-15
Substituted Phenylpiperazinyl Aralkylalcohol Derivatives, Pharmaceutical Compositions Containing Such Derivatives and Uses Thereof App 20110294822 - Li; Jianqi ; et al.	2011-12-01
Aralkyl Piperidine Derivatives And Their Uses As Antalgic Or Ataractic Agent App 20110105503 - Li; Jianqi ; et al.	2011-05-05
Process for the preparation of gabapentin hydrochloride Grant 7,667,071 - Peng , et al. February 23, 2	2010-02-23
Process for the preparation of gabapentin hydrochloride App 20090099362 - Peng; Zhenyun ; et al.	2009-04-16
Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent Grant 7,332,495 - Li , et al. February 19, 2	2008-02-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.